377 results
8-K
EX-99.1
3n4sb4l6tc nyby6jl
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
8-K
EX-1.1
9a81ke
26 Feb 24
Other Events
5:08pm
8-K
EX-4.2
lctljcqvfkdtge eon3k
26 Feb 24
Other Events
5:08pm
424B5
5bmhy9h4g9 qyl
26 Feb 24
Prospectus supplement for primary offering
6:12am
424B5
tevjw37wioohl
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
m1uiskcl1 dz
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
EX-99.1
tb16k9jqmaoqkt
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
EX-99.1
j0fnd l05
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
EX-99.2
qkwhv8
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.1
g5e5ae193i
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
kla4vn2e0rmh8w cq
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm